MANIFOLD
Will TNX-102 SL Receive FDA Approval for the Treatment of Fibromyalgia?
2
Ṁ100Ṁ894
resolved Oct 13
Resolved
YES

This market predicts whether the FDA will approve TNX-102 SL for treating fibromyalgia. The FDA has accepted the NDA and given Fast Track designation. Resolution will be based on official FDA announcements and Tonix press releases.

References:

Market context
Get
Ṁ1,000
to start trading!

🏅 Top traders

#TraderTotal profit
1Ṁ76
2Ṁ13
© Manifold Markets, Inc.TermsPrivacy